Tested Applications
| Positive WB detected in | HeLa cells |
| Positive IHC detected in | human stomach tissue, human appendicitis tissue, human ovary cancer tissue, human intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10696-1-AP targets FBXO7 in WB, IHC, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1035 Product name: Recombinant human FBXO7 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 220-522 aa of BC008361 Sequence: KALSMPEKWKLSGVYKLQYMHPLCEGSSATLTCVPLGNLIVVNATLKINNEIRSVKRLQLLPESFICKEKLGENVANIYKDLQKLSRLFKDQLVYPLLAFTRQALNLPDVFGLVVLPLELKLRIFRLLDVRSVLSLSAVCRDLFTASNDPLLWRFLYLRDFRDNTVRVQDTDWKELYRKRHIQRKESPKGRFVMLLPSSTHTIPFYPNPLHPRPFPSSRLPPGIIGGEYDQRPTLPYVGDPISSLIPGPGETPSQFPPLRPRFDPVGPLPGPNPILPGRGGPNDRFPFRPSRGRPTDGRLSFM Predict reactive species |
| Full Name | F-box protein 7 |
| Calculated Molecular Weight | 59 kDa |
| Observed Molecular Weight | 59-75 kDa |
| GenBank Accession Number | BC008361 |
| Gene Symbol | FBXO7 |
| Gene ID (NCBI) | 25793 |
| RRID | AB_2246820 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y3I1 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
FBXO7, also named as FBX7, is a substrate recognition component of a (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. FBXO7 recognizes BIRC2 and DLGAP5. It function in phosphorylation-dependent ubiquitination.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for FBXO7 antibody 10696-1-AP | Download protocol |
| WB protocol for FBXO7 antibody 10696-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The FBXO7 Polyclonal antibody (Cat# 10696-1-AP) has 3 citations. They appear in Hepatology, Cell Death Dis, and JCI Insight. The research fields span hepatocellular carcinoma (HDAC inhibitors and topoisomerase IIα degradation), diabetic kidney disease (tubulointerstitial fibrosis and mitophagy), and neuroprotection (inflammation and PINK1 stabilization).
| Species | Application | Title |
|---|---|---|
Hepatology Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells. | ||
Cell Death Dis Tubular tRF‑1:30‑Gln‑CTG‑4 attenuates tubulointerstitial fibrosis by mitigating FBXO7-mediated mitophagy defect in diabetic kidney disease. | ||
JCI Insight Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1. |









